CPS1
Carbamoyl-phosphate synthase [ammonia], mitochondrial
Also known as: CPSM_HUMAN, GATD6
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P31327
- Gene
- CPS1
- Ensembl
- ENSG00000021826
- Chromosome
- 2
- Canonical length
- 1500 aa
- Protein class
- Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoli,Nucleoli rim,Mid piece,Principal piece
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
The mitochondrial enzyme encoded by this gene catalyzes synthesis of carbamoyl phosphate from ammonia and bicarbonate. This reaction is the first committed step of the urea cycle, which is important in the removal of excess urea from cells. The encoded protein may also represent a core mitochondrial nucleoid protein. Three transcript variants encoding different isoforms have been found for this gene. The shortest isoform may not be localized to the mitochondrion. Mutations in this gene have been associated with carbamoyl phosphate synthetase deficiency, susceptibility to persistent pulmonary hypertension, and susceptibility to venoocclusive disease after bone marrow transplantation.[provided by RefSeq, May 2010]
Canonical amino-acid sequenceUniProt
1500 residues, UniProt reviewed canonical sequence.
>P31327|CPS1
1 MTRILTAFKV VRTLKTGFGF TNVTAHQKWK FSRPGIRLLS VKAQTAHIVL EDGTKMKGYS
61 FGHPSSVAGE VVFNTGLGGY PEAITDPAYK GQILTMANPI IGNGGAPDTT ALDELGLSKY
121 LESNGIKVSG LLVLDYSKDY NHWLATKSLG QWLQEEKVPA IYGVDTRMLT KIIRDKGTML
181 GKIEFEGQPV DFVDPNKQNL IAEVSTKDVK VYGKGNPTKV VAVDCGIKNN VIRLLVKRGA
241 EVHLVPWNHD FTKMEYDGIL IAGGPGNPAL AEPLIQNVRK ILESDRKEPL FGISTGNLIT
301 GLAAGAKTYK MSMANRGQNQ PVLNITNKQA FITAQNHGYA LDNTLPAGWK PLFVNVNDQT
361 NEGIMHESKP FFAVQFHPEV TPGPIDTEYL FDSFFSLIKK GKATTITSVL PKPALVASRV
421 EVSKVLILGS GGLSIGQAGE FDYSGSQAVK AMKEENVKTV LMNPNIASVQ TNEVGLKQAD
481 TVYFLPITPQ FVTEVIKAEQ PDGLILGMGG QTALNCGVEL FKRGVLKEYG VKVLGTSVES
541 IMATEDRQLF SDKLNEINEK IAPSFAVESI EDALKAADTI GYPVMIRSAY ALGGLGSGIC
601 PNRETLMDLS TKAFAMTNQI LVEKSVTGWK EIEYEVVRDA DDNCVTVCNM ENVDAMGVHT
661 GDSVVVAPAQ TLSNAEFQML RRTSINVVRH LGIVGECNIQ FALHPTSMEY CIIEVNARLS
721 RSSALASKAT GYPLAFIAAK IALGIPLPEI KNVVSGKTSA CFEPSLDYMV TKIPRWDLDR
781 FHGTSSRIGS SMKSVGEVMA IGRTFEESFQ KALRMCHPSI EGFTPRLPMN KEWPSNLDLR
841 KELSEPSSTR IYAIAKAIDD NMSLDEIEKL TYIDKWFLYK MRDILNMEKT LKGLNSESMT
901 EETLKRAKEI GFSDKQISKC LGLTEAQTRE LRLKKNIHPW VKQIDTLAAE YPSVTNYLYV
961 TYNGQEHDVN FDDHGMMVLG CGPYHIGSSV EFDWCAVSSI RTLRQLGKKT VVVNCNPETV
1021 STDFDECDKL YFEELSLERI LDIYHQEACG GCIISVGGQI PNNLAVPLYK NGVKIMGTSP
1081 LQIDRAEDRS IFSAVLDELK VAQAPWKAVN TLNEALEFAK SVDYPCLLRP SYVLSGSAMN
1141 VVFSEDEMKK FLEEATRVSQ EHPVVLTKFV EGAREVEMDA VGKDGRVISH AISEHVEDAG
1201 VHSGDATLML PTQTISQGAI EKVKDATRKI AKAFAISGPF NVQFLVKGND VLVIECNLRA
1261 SRSFPFVSKT LGVDFIDVAT KVMIGENVDE KHLPTLDHPI IPADYVAIKA PMFSWPRLRD
1321 ADPILRCEMA STGEVACFGE GIHTAFLKAM LSTGFKIPQK GILIGIQQSF RPRFLGVAEQ
1381 LHNEGFKLFA TEATSDWLNA NNVPATPVAW PSQEGQNPSL SSIRKLIRDG SIDLVINLPN
1441 NNTKFVHDNY VIRRTAVDSG IPLLTNFQVT KLFAEAVQKS RKVDSKSLFH YRQYSAGKAALocalizationUniProt · AlphaFold · HPA
Whether an antibody against CPS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.19
- Highest tissue expression
- 995 nTPM
Expression across tissuesHPA
Tissue
- liver: 995 nTPM
- duodenum: 199 nTPM
- small intestine: 116 nTPM
- spinal cord: 3.3 nTPM
- epididymis: 2.6 nTPM
- midbrain: 2.5 nTPM
Single-cell type
- hepatocytes: 2,627 nCPM
- enterocytes: 131 nCPM
- early spermatids: 95 nCPM
- enteric transient amplifying cells: 76 nCPM
- paneth cells: 66 nCPM
- syncytiotrophoblasts: 64 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- basal ganglia: 21 nTPM
- midbrain: 19 nTPM
- medulla oblongata: 15 nTPM
- white matter: 14 nTPM
- thalamus: 13 nTPM
- cerebellum: 11 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CPS1.
Disease | AllUniProt
Conditions CPS1 is implicated in, by any mechanism.
- Carbamoyl phosphate synthetase 1 deficiency (CPS1D) MIM:237300
Disease | GeneticClinVar
402 pathogenic / likely-pathogenic of 2,250 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Congenital hyperammonemia, type I
- Pulmonary hypertension, neonatal, susceptibility to
- CPS1-related disorder
- Inborn genetic diseases
- Uterine corpus endometrial carcinoma
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.52
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.46
- DepMap mean gene effect
- 0.15
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 'de novo' pyrimidine nucleobase biosynthetic process
- cellular response to ammonium ion
- cellular response to cAMP
- cellular response to fibroblast growth factor stimulus
- cellular response to glucagon stimulus
- cellular response to oleic acid
- citrulline biosynthetic process
- glutamine metabolic process
- hepatocyte differentiation
- homocysteine metabolic process
- midgut development
- monoatomic anion homeostasis
- nitric oxide metabolic process
- response to alcohol
- response to amine
- response to amino acid
- response to dexamethasone
- response to food
- response to growth hormone
- response to lipopolysaccharide
- response to starvation
- response to toxic substance
- response to xenobiotic stimulus
- response to zinc ion
- triglyceride catabolic process
- urea cycle
- vasodilation
- carbamoyl phosphate biosynthetic process
Molecular functions
- ATP binding
- calcium ion binding
- carbamoyl-phosphate synthase (ammonia) activity
- carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity
- endopeptidase activity
- glutamate binding
- metal ion binding
- modified amino acid binding
- phospholipid binding
- potassium ion binding
- protein-containing complex binding
- small molecule binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Carbamoyl-phosphate synthase small subunit, N-terminal domain
- Carbamoyl phosphate synthase, ATP-binding domain
- Carbamoyl-phosphate synthetase, large subunit oligomerisation domain
- Carbamoyl phosphate synthase, CPSase domain
- Carbamoyl-phosphate synthase, small subunit
- Carbamoyl-phosphate synthase, large subunit
- Methylglyoxal synthase-like domain
- ATP-grasp fold
- ATP-grasp fold, subdomain 1
- Pre-ATP-grasp domain superfamily
- Glutamine amidotransferase
- Class I glutamine amidotransferase-like
- Carbamoyl-phosphate synthase small subunit, GATase1 domain
- Carbamoyl-phosphate synthase small subunit, N-terminal domain superfamily
- Carbamoyl-phosphate synthetase, large subunit oligomerisation domain superfamily
- Methylglyoxal synthase-like domain superfamily
- Carbamoyl phosphate synthase, preATP-grasp domain
- Glutamine amidotransferase class-I
- Carbamoyl-phosphate synthase small chain, CPSase domain
- MGS-like domain
- Carbamoyl-phosphate synthase L chain, ATP binding domain
- Carbamoyl-phosphate synthetase large chain, oligomerisation domain
- Carbamoyl phosphate synthase preATP-grasp domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CPS1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CPS1 as an antibody target. Whether an autoantibody or antibody against CPS1 could matter depends on whether native CPS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CPS1 is annotated at the cell surface, where native CPS1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CPS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...